Newlans, Inc. Closes $20 Million Series B Financing With $5 Million from Verizon Ventures

May 29, 2014

Newlans, a technology innovator in RF solutions, today announced that it has raised an additional $5 million investment from Verizon Ventures to complete its Series B financing round, totaling $20 million. The initial $15 million closing in February included existing investors Paladin Capital and Lockheed Martin, as well as two new strategic partners. The funding will be used to accelerate the development and commercialization of Newlans’ Programmable Duplexer, targeting front-end radio frequency modules for 4G LTE mobile devices and small cells.

Twist Bioscience Secures $31.1 Million

May 27, 2014

Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize the company’s semiconductor-based synthetic gene manufacturing process. Nick and Joby Pritzker, through their family’s firm Tao Invest, led the round, with participation from ARCH Venture Partners, Paladin Capital Group, Yuri Milner and additional strategic corporate and venture investors.